Beleave Inc.
Beleave Inc.
Indice CSE:
Devise:
Beleave Inc. ("Beleave" or the "Company") is a biotech company focused on the production of medical marijuana in Canada. The Company's wholly-owned subsidiary First Access Medical Inc. has applied for a license to cultivate and sell medical marijuana at its facility pursuant to the Access to Cannabis for Medical Purposes Regulations outlined by Health Canada. The Company is actively working towards the development of patents through research with large Canadian institutions and the research and development of smoke harm reduction products.
Beleave Inc. (BE)
SEDAR Information
Information d'entreprise
Addresse
1653 Hwy No. 6 North
Flamborough, ON L8N 2Z7
CanadaTéléphone
905-979-5173Courriel
info@beleave.comURL
http://www.beleave.comDate d’inscription à la cote
Jeudi, décembre 31, 2015Relations avec les investisseurs
sebastian@beleave.comVérificateur
MNP LLPCapitalisation
Capitalisation:
509860225Réservé à l'émission:
74631291Company Officers
Bill Panagiotakopoulos, Acting CEO
Bill Panagiotakopoulos, COO
Communiqués de presse
Bulletins
02/02/2021
2021-0206 - Radiation - Beleave Inc. (BE)
Le 2 février/February 2021
The common shares of Beleave Inc. will be delisted at the market close today February 2, 2021.
Beleave is currently suspended. See bulletin 2020-0802.
___________________
Les actions ordinaires de Beleave Inc. seront radiées à la clôture du marché aujourd'hui le 2 février 2021.
